CureDM Competitors and Similar CompaniesClear all

CureDM's competitors and similar companies include Abarceo Pharma, glyscend, REMD Biotherapeutics and Alteogen.
CureDM
CureDM
CureDM is a biopharmaceutical company that provides therapies to treat diabetes.
Abarceo Pharma
Abarceo Pharma
Abarceo Pharma is a company that develops therapeutics for type-2 diabetes.
glyscend
glyscend
glyscend is a company that develops a method of treating metabolic diseases.
REMD Biotherapeutics
REMD Biotherapeutics
REMD Biotherapeutics is a biopharmaceutical company focusing on bio-medicines to treat cancer, diabetes, and other diseases.
Alteogen
Alteogen
Alteogen ((주)알테오젠) is a biopharmaceutical company that develops therapeutic proteins, antibody-drug conjugates, (ADC), and monoclonal antibody biosimilars.
Founding Date
Founding Date
2004
Founding Date
2017
Founding Date
2014
Founding Date
2011
Founding Date
2008
Type
Type
Subsidiary
Type
Private
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Wilmington, US HQ
Locations
Malmö, SE HQ
Locations
Baltimore, US HQ
Lowell, US
Locations
Camarillo, US HQ
Beijing, CN
Locations
Daejeon, KR HQ
Seoul, KR
Employees
Employees
3
Employees
910% decrease
Employees
9
Employees
6
Employees
155

Funding

Total funding raised
Total funding raised
$ 4.6m
Total funding raised
N/A
Total funding raised
$ 21m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Abarceo Pharma
HQ
Malmö, SE
Employees
9↓ 10% decrease

Abarceo Pharma is a company that develops therapeutics for type-2 diabetes.

View company
glyscend
HQ
Baltimore, US
Employees
9

glyscend is a company that develops a method of treating metabolic diseases.

View company
REMD Biotherapeutics
HQ
Camarillo, US
Employees
6

REMD Biotherapeutics is a biopharmaceutical company focusing on bio-medicines to treat cancer, diabetes, and other diseases.

View company
Alteogen
HQ
Daejeon, KR
Employees
155

Alteogen ((주)알테오젠) is a biopharmaceutical company that develops therapeutic proteins, antibody-drug conjugates, (ADC), and monoclonal antibody biosimilars.

View company